Biotech

All Articles

Lundbeck indications $2.5 B look for Longboard and its own epilepsy med

.After spying smash hit possibility in Longboard Pharmaceuticals' epilepsy med, brain disease-focuse...

Lilly decides on UK for 1st Gateway Lab in Europe

.Eli Lilly's Entrance Labs is going global, with the U.K. government declaring today that the nation...

Jasper dials up dosage after colonies feedbacks come and go rapidly

.Jasper Rehab has reported total responses in 10 of the 12 persistent hives patients that received t...

Transgene's virus-like cancer cells vaccination flunks midphase examination

.Transgene's restorative vaccine prospect TG4001 has failed a stage 2 strong tumor trial. Yet, while...

Upstream swells IPO to $255M as it specifies together with CAMP4

.Upstream Bio possesses swollen its IPO to $255 million as the business participates in CAMP4 Therap...

Sanofi flunks MS research, dealing another strike to Denali deal

.Sanofi has actually quit a stage 2 difficulty of Denali Therapeutics-partnered oditrasertib in vari...

Turnstone gives up 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is actually reducing its headcount through 60% and agitating its own C-suite in...

Gilead surrenders on $15M MASH bet after weighing preclinical data

.In a year that has actually found an authorization as well as a plethora of readouts for metabolic ...

Texas biotech axes cancer cells deal, pins hopes on obesity

.Alaunos Rehabs is actually axing a deal along with Precigen, quiting licensing rights to a tailored...

Capricor shares even more information for DMD therapy after triggering BLA

.Capricor Therapeutics is taking a success lap for their phase 2 Duchenne muscular dystrophy (DMD) t...